Timothy Mayer, Ph.D.   |   Chief Operating Officer

Dr. Mayer has extensive experience in the biopharmaceutical industry, including antibody therapeutics, small molecule pharmaceuticals and laboratory cloning systems. Prior to joining NextCure, he was at MacroGenics where he oversaw all intellectual property matters, assisted business development in various licensing transactions and helped facilitate its IPO. Dr. Mayer also worked at Banner & Witcoff, an intellectual property law firm, where he drafted and prosecuted biotech and pharmaceutical applications and conducted patentability and freedom-to-operate searches in all areas of biotechnology and small molecule chemistry. Dr. Mayer also worked for Life Technologies and Invitrogen where he developed cloning systems. Dr. Mayer received his Ph.D. in Microbiology and Immunology from Penn State University College of Medicine and B.S. degrees in Microbiology and Biochemistry from California Polytechnic State University. • Michael Richman
President & CEO

• Timothy Mayer, Ph.D.

• Steven P. Cobourn, CPA

• Han Myint, M.D.

• Sol Langermann, Ph.D.

• Sourav Kundu, Ph.D.
Senior Vice-President, Development & Manufacturing

• Sebastien Maloveste, Ph.D.
Vice President, Business Development

• Dallas Flies, Ph.D.
Vice President, Discovery Research

• Zachary Cusumano, Ph.D.
Vice President, Research & Project Planning